Enalare Therapeutics
President of National Spine and Pain Centers, the nation’s largest MSO serving interventional pain management practices, and enterprise of over 1,000 employees. Dr. Coleman is also a highly sought after pharmaceutical and medical device company consultant and scientific advisor whose clients have included Abbott, Medtronic, and Collegium among many others. He was an advisor early in the formation of Axsome Therapeutics (NASDAQ: AXSM) and has been a member of its board of directors since 2014. He is a graduate of Wesleyan University and received his medical degree from Johns Hopkins University School of Medicine. Dr. Coleman is also a Diplomat of the American Board of Anesthesiology.
This person is not in the org chart
This person is not in any offices
Enalare Therapeutics
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.